• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NAC1 减弱了 BCL6 的负反馈调控,并作为 BCL6 的共激活因子,促进了肿瘤细胞中 FOXQ1 的转录。

NAC1 attenuates BCL6 negative autoregulation and functions as a BCL6 coactivator of FOXQ1 transcription in cancer cells.

机构信息

Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, PR China.

Departments of Gynecology and Obstetrics, Oncology and Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA.

出版信息

Aging (Albany NY). 2020 May 14;12(10):9275-9291. doi: 10.18632/aging.103203.

DOI:10.18632/aging.103203
PMID:32412910
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7288929/
Abstract

BACKGROUND

Nucleus accumbens-associated protein 1 (NAC1) has multifaceted roles in cancer pathogenesis and progression, including the development of drug resistance, promotion of cytokinesis, and maintenance of "stem cell-like" phenotypes. NAC1 is a transcriptional co-regulator belonging to the bric-a-brac tramtrack broad (BTB) family of proteins, although it lacks the characteristic DNA binding motif of the BTB family. The formation of higher-order transcription complexes likely depends on its interaction with other DNA-binding co-factors.

RESULTS

NAC1 interacts with BCL6 via its C-terminal BEN domain and forms a complex that binds the promoter region and activates transcription of the NAC1 target gene, FOXQ1. NAC1 and BCL6 were coordinately upregulated. Our analysis also identified a novel function of NAC1 in attenuating BCL6 auto-downregulation in ovarian cancer. Lastly, we found a significant overlap among NAC1- and BCL6-regulated genes in tumor cells, suggesting that NAC1 and BCL6 coordinately control transcription in cancer.

CONCLUSIONS

The results of this study provide a novel mechanistic insight into the oncogenic roles of NAC1 and underline the importance of developing the NAC1/BCL6-targeted cancer therapy.

METHODS

Using the Cistrome database and Chromatin Immunoprecipitation (ChIP) analyses, we identified BCL6 as a potential NAC1- interacting molecule. Co-immunoprecipitation (Co-IP), luciferase reporter assay, immunohistochemistry and microarray analysis were performed to analyze the interaction between NAC1 and BCL6 and the mechanisms by which they regulate the downstream genes including FOXQ1.

摘要

背景

伏隔核相关蛋白 1(NAC1)在癌症的发病机制和进展中具有多方面的作用,包括耐药性的发展、细胞分裂的促进以及“干细胞样”表型的维持。NAC1 是一种转录共调节剂,属于 bric-a-brac tramtrack broad(BTB)蛋白家族,尽管它缺乏 BTB 家族的特征性 DNA 结合基序。高等转录复合物的形成可能依赖于其与其他 DNA 结合共因子的相互作用。

结果

NAC1 通过其 C 端 BEN 结构域与 BCL6 相互作用,并形成一个复合物,该复合物结合启动子区域并激活 NAC1 靶基因 FOXQ1 的转录。NAC1 和 BCL6 协同上调。我们的分析还确定了 NAC1 在卵巢癌细胞中减弱 BCL6 自身下调的新功能。最后,我们发现肿瘤细胞中 NAC1 和 BCL6 调节的基因之间存在显著重叠,表明 NAC1 和 BCL6 协同控制癌症中的转录。

结论

本研究的结果为 NAC1 的致癌作用提供了新的机制见解,并强调了开发针对 NAC1/BCL6 的癌症治疗的重要性。

方法

使用 Cistrome 数据库和染色质免疫沉淀(ChIP)分析,我们确定了 BCL6 是 NAC1 的潜在相互作用分子。通过共免疫沉淀(Co-IP)、荧光素酶报告基因分析、免疫组织化学和微阵列分析,我们分析了 NAC1 和 BCL6 之间的相互作用以及它们调节下游基因(包括 FOXQ1)的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caba/7288929/80147c49cbaf/aging-12-103203-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caba/7288929/4732becec1fa/aging-12-103203-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caba/7288929/46e8dd0f3232/aging-12-103203-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caba/7288929/ce6e0a0a928c/aging-12-103203-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caba/7288929/f785da82189f/aging-12-103203-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caba/7288929/52b85e7e6abe/aging-12-103203-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caba/7288929/b42faedcd388/aging-12-103203-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caba/7288929/bd115f6014fb/aging-12-103203-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caba/7288929/80147c49cbaf/aging-12-103203-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caba/7288929/4732becec1fa/aging-12-103203-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caba/7288929/46e8dd0f3232/aging-12-103203-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caba/7288929/ce6e0a0a928c/aging-12-103203-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caba/7288929/f785da82189f/aging-12-103203-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caba/7288929/52b85e7e6abe/aging-12-103203-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caba/7288929/b42faedcd388/aging-12-103203-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caba/7288929/bd115f6014fb/aging-12-103203-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caba/7288929/80147c49cbaf/aging-12-103203-g008.jpg

相似文献

1
NAC1 attenuates BCL6 negative autoregulation and functions as a BCL6 coactivator of FOXQ1 transcription in cancer cells.NAC1 减弱了 BCL6 的负反馈调控,并作为 BCL6 的共激活因子,促进了肿瘤细胞中 FOXQ1 的转录。
Aging (Albany NY). 2020 May 14;12(10):9275-9291. doi: 10.18632/aging.103203.
2
Identification of the NAC1-regulated genes in ovarian cancer.鉴定卵巢癌中 NAC1 调控的基因。
Am J Pathol. 2014 Jan;184(1):133-40. doi: 10.1016/j.ajpath.2013.09.024. Epub 2013 Nov 6.
3
Nucleus Accumbens 1, a Pox virus and Zinc finger/Bric-a-brac Tramtrack Broad protein binds to TAR DNA-binding protein 43 and has a potential role in Amyotrophic Lateral Sclerosis.伏核 1、痘病毒和锌指/Brick-a-brac Tramtrack Broad 蛋白与 TAR DNA 结合蛋白 43 结合,并在肌萎缩性侧索硬化症中具有潜在作用。
Neuroscience. 2012 Dec 27;227:44-54. doi: 10.1016/j.neuroscience.2012.09.043. Epub 2012 Sep 25.
4
NAC1, a POZ/BTB protein that functions as a corepressor.NAC1,一种作为共抑制因子发挥作用的POZ/BTB蛋白。
Neurochem Int. 2009 Mar-Apr;54(3-4):245-52. doi: 10.1016/j.neuint.2008.12.008. Epub 2008 Dec 13.
5
Dysfunction of nucleus accumbens-1 activates cellular senescence and inhibits tumor cell proliferation and oncogenesis.伏隔核 1 功能障碍会激活细胞衰老,并抑制肿瘤细胞增殖和癌变。
Cancer Res. 2012 Aug 15;72(16):4262-75. doi: 10.1158/0008-5472.CAN-12-0139. Epub 2012 Jun 4.
6
Structures of heterodimeric POZ domains of Miz1/BCL6 and Miz1/NAC1.Miz1/BCL6和Miz1/NAC1异二聚体POZ结构域的结构
Acta Crystallogr F Struct Biol Commun. 2014 Dec 1;70(Pt 12):1591-6. doi: 10.1107/S2053230X14023449. Epub 2014 Nov 14.
7
Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein.共抑制因子SMRT与LAZ3/BCL6癌蛋白的BTB/POZ抑制结构域结合。
Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10762-7. doi: 10.1073/pnas.94.20.10762.
8
BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.BCL6通过不同的生化机制使淋巴瘤细胞得以存活和分化。
Blood. 2007 Sep 15;110(6):2067-74. doi: 10.1182/blood-2007-01-069575. Epub 2007 Jun 1.
9
NAC1, a cocaine-regulated POZ/BTB protein interacts with CoREST.NAC1,一种受可卡因调节的POZ/BTB蛋白,与CoREST相互作用。
J Neurochem. 2007 May;101(3):611-8. doi: 10.1111/j.1471-4159.2006.04387.x. Epub 2007 Jan 24.
10
NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response.NAC1 通过改变 HMGB1 介导线粒体自噬反应来调节卵巢癌细胞对顺铂的敏感性。
Oncogene. 2012 Feb 23;31(8):1055-64. doi: 10.1038/onc.2011.290. Epub 2011 Jul 11.

引用本文的文献

1
Progress of targeted FOX family therapy in ovarian cancer.卵巢癌中靶向FOX家族治疗的进展
Front Pharmacol. 2025 Jul 17;16:1604998. doi: 10.3389/fphar.2025.1604998. eCollection 2025.
2
MicroRNAs signatures as potential molecular markers in mild cognitive impairment: a meta-analysis.微小RNA特征作为轻度认知障碍潜在分子标志物的Meta分析
Front Aging Neurosci. 2025 Jan 15;16:1524622. doi: 10.3389/fnagi.2024.1524622. eCollection 2024.
3
Molecular mechanisms of mTOR-mediated cisplatin response in tumor cells.肿瘤细胞中mTOR介导的顺铂反应的分子机制。

本文引用的文献

1
GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis.GEPIA2:一个用于大规模表达谱分析和交互式分析的增强型网络服务器。
Nucleic Acids Res. 2019 Jul 2;47(W1):W556-W560. doi: 10.1093/nar/gkz430.
2
Identification of a small-molecule compound that inhibits homodimerization of oncogenic NAC1 protein and sensitizes cancer cells to anticancer agents.鉴定一种小分子化合物,该化合物能抑制致癌 NAC1 蛋白的同源二聚化,并使癌细胞对抗癌药物敏感。
J Biol Chem. 2019 Jun 21;294(25):10006-10017. doi: 10.1074/jbc.RA119.007664. Epub 2019 May 17.
3
A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay.
Heliyon. 2024 Dec 25;11(1):e41483. doi: 10.1016/j.heliyon.2024.e41483. eCollection 2025 Jan 15.
4
The transcription factor FOXQ1 in cancer.癌症中的转录因子FOXQ1
Cancer Metastasis Rev. 2025 Jan 8;44(1):22. doi: 10.1007/s10555-025-10240-y.
5
An intellectual-disability-associated mutation of the transcriptional regulator impairs glutamatergic neurotransmission.转录调节因子的一种与智力残疾相关的突变会损害谷氨酸能神经传递。
Front Mol Neurosci. 2023 Jul 14;16:1115880. doi: 10.3389/fnmol.2023.1115880. eCollection 2023.
6
miR-18a-5p derived from mesenchymal stem cells-extracellular vesicles inhibits ovarian cancer cell proliferation, migration, invasion, and chemotherapy resistance.间充质干细胞来源的外泌体 miR-18a-5p 抑制卵巢癌细胞增殖、迁移、侵袭和化疗耐药性。
J Transl Med. 2022 Jun 7;20(1):258. doi: 10.1186/s12967-022-03422-7.
7
Transcriptional inhibition of miR-486-3p by BCL6 upregulates Snail and induces epithelial-mesenchymal transition during radiation-induced pulmonary fibrosis.BCL6 通过转录抑制 miR-486-3p 上调 Snail,诱导放射性肺纤维化中的上皮间质转化。
Respir Res. 2022 Apr 28;23(1):104. doi: 10.1186/s12931-022-02024-7.
8
ALOX5AP Predicts Poor Prognosis by Enhancing M2 Macrophages Polarization and Immunosuppression in Serous Ovarian Cancer Microenvironment.ALOX5AP通过增强浆液性卵巢癌微环境中M2巨噬细胞极化和免疫抑制来预测不良预后。
Front Oncol. 2021 May 19;11:675104. doi: 10.3389/fonc.2021.675104. eCollection 2021.
9
Inhibition of CXCR2 plays a pivotal role in re-sensitizing ovarian cancer to cisplatin treatment.抑制 CXCR2 在重新敏化卵巢癌对顺铂治疗的作用中起着关键作用。
Aging (Albany NY). 2021 May 26;13(10):13405-13420. doi: 10.18632/aging.203074.
10
Genetic analysis of zebrafish homologs of human FOXQ1, foxq1a and foxq1b, in innate immune cell development and bacterial host response.斑马鱼 FOXQ1 及其同源物 foxq1a 和 foxq1b 在固有免疫细胞发育和细菌宿主反应中的遗传分析。
PLoS One. 2018 Mar 13;13(3):e0194207. doi: 10.1371/journal.pone.0194207. eCollection 2018.
NACC1基因中的一种复发性新生变异导致一种以婴儿癫痫、白内障和严重发育迟缓为特征的综合征。
Am J Hum Genet. 2017 Feb 2;100(2):343-351. doi: 10.1016/j.ajhg.2016.12.013. Epub 2017 Jan 26.
4
miR-339-5p inhibits migration and invasion in ovarian cancer cell lines by targeting NACC1 and BCL6.微小RNA-339-5p通过靶向NACC1和BCL6抑制卵巢癌细胞系的迁移和侵袭。
Tumour Biol. 2016 Apr;37(4):5203-11. doi: 10.1007/s13277-015-4390-2. Epub 2015 Nov 9.
5
BCL6 is a negative prognostic factor and exhibits pro-oncogenic activity in ovarian cancer.BCL6是一种负性预后因素,在卵巢癌中表现出促癌活性。
Am J Cancer Res. 2014 Dec 15;5(1):255-66. eCollection 2015.
6
Morphological and quantitative analysis of BCL6 expression in human colorectal carcinogenesis.BCL6 在人类结直肠癌发生中的形态学和定量分析。
Oncol Rep. 2014 Jan;31(1):103-10. doi: 10.3892/or.2013.2846. Epub 2013 Nov 13.
7
Identification of the NAC1-regulated genes in ovarian cancer.鉴定卵巢癌中 NAC1 调控的基因。
Am J Pathol. 2014 Jan;184(1):133-40. doi: 10.1016/j.ajpath.2013.09.024. Epub 2013 Nov 6.
8
MicroRNA-127 is downregulated by Tudor-SN protein and contributes to metastasis and proliferation in breast cancer cell line MDA-MB-231.微 RNA-127 受 Tudor-SN 蛋白下调,促进乳腺癌 MDA-MB-231 细胞系的转移和增殖。
Anat Rec (Hoboken). 2013 Dec;296(12):1842-9. doi: 10.1002/ar.22823. Epub 2013 Oct 24.
9
Glioblastoma stem cells are regulated by interleukin-8 signaling in a tumoral perivascular niche.胶质母细胞瘤干细胞在肿瘤血管周龛中受白细胞介素-8 信号的调节。
Cancer Res. 2013 Dec 1;73(23):7079-89. doi: 10.1158/0008-5472.CAN-13-1355. Epub 2013 Oct 11.
10
Loss of NAC1 expression is associated with defective bony patterning in the murine vertebral axis.NAC1 表达缺失与小鼠脊柱骨形态形成缺陷有关。
PLoS One. 2013 Jul 26;8(7):e69099. doi: 10.1371/journal.pone.0069099. Print 2013.